Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy.

Comments on this publication

ResearchGate members can add comments. Sign up now and post your comment!

Similar publications

• Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.

  Authors: Rinrada Kietadisorn, Rio P Juni, An L Moens

  American journal of physiology. Endocrinology and metabolism. 302(5):E481-95.

• Endothelial dysfunction and subclinical hypothyroidism: A brief review.

  Authors: S La Vignera, R Condorelli, E Vicari, A E Calogero

  Journal of endocrinological investigation. 35(1):96-103.

• Sepiapterin improves angiogenesis of pulmonary artery endothelial cells with in utero pulmonary hypertension by recoupling endothelial nitric oxide synthase.

  Authors: Ru-Jeng Teng, Jianhai Du, Hao Xu, Ivane Bakhutashvili, Annie Eis, Yang Shi, Kirkwood A Pritchard, Girija G Konduri

  American journal of physiology. Lung cellular and molecular physiology. 301(3):L334-45.

• Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.

  Authors: Felix Fleissner, Thomas Thum

  Antioxidants & redox signaling. 15(4):933-48.

• Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1.

  Authors: Arpeeta Sharma, Andy Trane, Carol Yu, Jean-Francois Jasmin, Pascal Bernatchez

  European journal of pharmacology. 659(2-3):206-12.

Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.